Iovance Biotherapeutics (Medical Affairs)
IOVANCE Biotherapeutics is investigating Tumor Infiltrating Lymphocyte (TIL) cell therapy in patients with solid tumors and blood cancers.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No